Kaposi sarcoma is a multicentral tumor. The tumor is caused by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8).
- Advertising -
Report : Global Kaposi Sarcoma Market 2017-2021 is a new market research publication announced by Reportstack.
Report Outline: Kaposi sarcoma is a multicentral tumor. The tumor is caused by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8).
It can occur as endemic, classic, epidemic, and iatrogenic forms.
- Advertising -
The diagnosis is done by biopsy, and major treatment types include chemotherapy, HAART, and immunotherapy. HAART is the most common type of treatment due to a high prevalence rate of AIDS-associated Kaposi sarcoma.
For detailed report with TOC, please click here Global Kaposi Sarcoma Market 2017-2021
Market Growth: The global Kaposi sarcoma market to grow at a CAGR of 2.46% during the period 2017-2021.
• Bristol-Myers Squibb
• Johnson & Johnson
Other prominent vendors
• Eli Lilly
Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Eli Lilly and Pfizer.
Category: Market Research Publishers and RetailersCompany profile: Reportstack is one of the largest online libraries of market research publications. At Reportstack, users can find top-level research products from the leading publishers at one place. The best in practice web technology implemented by Reportstack enhances overall user experience and changes the way people buy research reports online. The market coverage spans across multiple verticals including but not limited to: Pharma & Healthcare, Automotive & Transport, Manufacturing & Industry ...
For more information: